Literature DB >> 16699965

Uncertainty and the ethics of clinical trials.

Sven Ove Hansson1.   

Abstract

A probabilistic explication is offered of equipoise and uncertainty in clinical trials. In order to be useful in the justification of clinical trials, equipoise has to be interpreted in terms of overlapping probability distributions of possible treatment outcomes, rather than point estimates representing expectation values. Uncertainty about treatment outcomes is shown to be a necessary but insufficient condition for the ethical defensibility of clinical trials. Additional requirements are proposed for the nature of that uncertainty. The indecisiveness of our criteria for cautious decision-making under uncertainty creates the leeway that makes clinical trials defensible.

Mesh:

Year:  2006        PMID: 16699965     DOI: 10.1007/s11017-006-0001-y

Source DB:  PubMed          Journal:  Theor Med Bioeth        ISSN: 1386-7415


  26 in total

1.  Why randomized controlled trials fail but needn't: 1. Failure to gain "coal-face" commitment and to use the uncertainty principle.

Authors:  D L Sackett
Journal:  CMAJ       Date:  2000-05-02       Impact factor: 8.262

Review 2.  Freedman's 'clinical equipoise' and sliding-scale all-dimensions-considered equipoise'.

Authors:  F Gifford
Journal:  J Med Philos       Date:  2000-08

3.  The ethics of placebo-controlled trials.

Authors:  Charles Weijer; Kathleen Cranley Glass
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

4.  Acknowledgment of uncertainty: a fundamental means to ensure scientific and ethical validity in clinical research.

Authors:  B Djulbegovic
Journal:  Curr Oncol Rep       Date:  2001-09       Impact factor: 5.075

5.  Placebo-controlled trials and the Declaration of Helsinki.

Authors:  John A Lewis; Bertil Jonsson; Gottfried Kreutz; Cristina Sampaio; Barbara van Zwieten-Boot
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

6.  Equipoise, knowledge and ethics in clinical research and practice.

Authors:  Richard Ashcroft
Journal:  Bioethics       Date:  1999-07       Impact factor: 1.898

Review 7.  Ethics of clinical trials from a bayesian and decision analytic perspective: whose equipoise is it anyway?

Authors:  Richard J Lilford
Journal:  BMJ       Date:  2003-05-03

8.  Continued need for placebo in many cases, even when there is effective therapy.

Authors:  Robert J Temple; Robert Meyer
Journal:  Arch Intern Med       Date:  2003-02-10

Review 9.  Community equipoise and the architecture of clinical research.

Authors:  J H Karlawish; J Lantos
Journal:  Camb Q Healthc Ethics       Date:  1997       Impact factor: 1.284

10.  Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go?

Authors:  C R Palmer
Journal:  Stat Methods Med Res       Date:  2002-10       Impact factor: 3.021

View more
  4 in total

1.  Do we need a special ethics for research?

Authors:  Sven Ove Hansson
Journal:  Sci Eng Ethics       Date:  2009-11-26       Impact factor: 3.525

2.  Protecting people in research: a comparison between biomedical and traffic research.

Authors:  Sara Svensson; Sven Ove Hannson
Journal:  Sci Eng Ethics       Date:  2007-03       Impact factor: 3.525

Review 3.  Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology.

Authors:  Enrique Gómez-Barrena; Philippe Rosset; Ingo Müller; Rosaria Giordano; Carmen Bunu; Pierre Layrolle; Yrjö T Konttinen; Frank P Luyten
Journal:  J Cell Mol Med       Date:  2011-06       Impact factor: 5.310

4.  Designing a placebo device: involving service users in clinical trial design.

Authors:  Rachael Gooberman-Hill; Clare Jinks; Sofia Barbosa Bouças; Kelly Hislop; Krysia S Dziedzic; Carol Rhodes; Amanda Burston; Jo Adams
Journal:  Health Expect       Date:  2013-01-14       Impact factor: 3.377

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.